(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THE AMERICAN BOARD OF NUCLEAR MEDICINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

THE AMERICAN BOARD OF NUCLEAR MEDICINE

ST13

US500000073465351

Class

42

Filing

73465351

Registration

1367120

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

08/05/2025

Trademark type

Word

Nice classes

42

Filing date

02/13/1984

Registration date

10/22/1985

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/14/2025

Last transaction

08/05/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

1971-10-00

First use in commerce

1971-10-00

Drawing code

1

Owner type

03

Owner location

St. Louis, MO

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

THE AMERICAN BOARD OF NUCLEAR MEDICINE, INC.
THE AMERICAN BOARD OF NUCLEAR MEDICINE, INC.
A. M. (pessoa física)

Representatives

THE AMERICAN BOARD OF NUCLEAR MEDICINE, INC.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

CONDUCTING COMPETENCY TESTS FOR PERSONS IN THE NUCLEAR MEDICINE FIELDAIDING IN THE ASSESSMENT AND ACCREDITATION OF NUCLEAR MEDICINE PROGRAMS IN HOSPITALS AND INSTITUTIONS WHICH PROVIDE GRADUATE PROGRAMS IN THAT FIELD

Publications

History of USPTO decisions and trademark events.

35 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/14/2025

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

07/14/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/14/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/14/2025

E89R

TEAS SECTION 8 & 9 RECEIVED

02/13/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/22/2024

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/22/2015

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

10/22/2015

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/22/2015

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

10/16/2015

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

10/15/2015

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

10/06/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/05/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/04/2015

E89R

TEAS SECTION 8 & 9 RECEIVED

09/04/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/23/2010

CFIT

CASE FILE IN TICRS

05/29/2008

UNDN

UNDELIVERABLE MAIL - NO ACTION TAKEN

05/03/2006

MAIL

PAPER RECEIVED

10/13/2005

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/28/2005

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/28/2005

PLGL

ASSIGNED TO PARALEGAL

09/26/2005

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

08/11/2005

MAIL

PAPER RECEIVED

08/11/2005

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/05/1991

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

11/05/1990

R.PR

REGISTERED-PRINCIPAL REGISTER

10/22/1985

PUBO

PUBLISHED FOR OPPOSITION

04/30/1985

NPUB

NOTICE OF PUBLICATION

03/29/1985

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/26/1985

CNEA

EXAMINERS AMENDMENT MAILED

02/25/1985

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/14/1984

DOCK

ASSIGNED TO EXAMINER

10/10/1984

CNRT

NON-FINAL ACTION MAILED

06/15/1984

DOCK

ASSIGNED TO EXAMINER

06/04/1984

Continuous trademark protection

Get notified about every new filing that threatens THE AMERICAN BOARD OF NUCLEAR MEDICINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.